Clinical Trials Logo

Autistic Disorder clinical trials

View clinical trials related to Autistic Disorder.

Filter by:

NCT ID: NCT06418035 Recruiting - Clinical trials for Autism Spectrum Disorder

Acquisition of Daily Living Skills in Autistic Children: Comparison Between QR Code and a Human Operator

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Autism spectrum disorder (ASD), is a condition characterized by deficits in social communication and mutual interaction, as well as repetitive and restricted behaviors and interests. This condition manifests itself differently in each individual and can vary greatly in severity and impact on daily life. Autistic children may present various challenges and difficulties in developing daily living skills (DLS). These difficulties may relate to various areas, such as personal autonomy and domestic autonomy. For example, they may have difficulties in acquiring personal hygiene skills, such as dressing and tying their shoes independently. They may have difficulty performing household tasks, such as setting the table, preparing a simple meal, or folding a t-shirt. These difficulties may require specific support and training to help autistic children develop personal autonomy skills and achieve greater independence in different areas of their daily lives. Improving and developing DLS is an important goal in order to improve the quality of life and independence of children with autistic conditions. This protocol aims to acquire new useful DLS within the various settings of daily life. The hypothesis of the present study is the following: video modeling, through the use of the iPad (Qr code scanning), can be more effective in promoting autonomy in children with ASD, compared to a control group that receives a traditional training, without the use of technological instrumentation.

NCT ID: NCT06417450 Recruiting - Clinical trials for Autism Spectrum Disorder

Usefulness of NESA Microcurrents in the Treatment of Children With Autism Spectrum Disorders

Start date: May 13, 2024
Phase: N/A
Study type: Interventional

The term or definition of Autism Spectrum Disorder (ASD) defines a pervasive neurodevelopmental disorder in which deficits in communication and social interaction, altered sensorimotor behaviours, repetitive, restricted and stereotyped interests and activities are observed. One of the disorders most frequently associated with ASD, and which most affects the quality of life of the child and his or her family, is sleep disorders; it is estimated that between 50 and 80 percent of children with ASD present this alteration and generally continue to suffer from it in adolescence and adulthood; It has also been observed that there is a correlation between sleep problems and an increase in aggressive behaviour, social and emotional deficits and deficits in activities of daily living, which severely affects the child and his or her close family environment; they become emotionally destabilised in a notorious way, and this has a negative impact on their work and productive environment. The microcurrents generated by the non-invasive neuromodulation device introduce, by means of a non-invasive technique (surface electrodes), electrical energy to normalise the nervous stimulus. This makes it an excellent complementary treatment to the activity of rehabilitation treatment. Its effects are achieved by establishing several input nerve pathways corresponding to the body's dermis, through which the signals are intellectualised in time-space. These signals are the basis for achieving normalisation of the nerve impulse by means of microcurrents.

NCT ID: NCT06415539 Recruiting - Clinical trials for Autism Spectrum Disorder

The Effect of Exercise Practices on Hyperactivity Levels in Children With Autism Spectrum Disorder

Start date: May 15, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effect of vestibular and proprioceptive exercise practices on the hyperactivity level in children with autism spectrum disorder.

NCT ID: NCT06403969 Not yet recruiting - Insomnia Clinical Trials

Sleep in Children With Autism and Intellectual Disability

SLEEP-AID IT
Start date: May 14, 2024
Phase: N/A
Study type: Interventional

Purposes: Establish proof-of-concept for home polysomnography in the assessment of sleep disorders among prepubertal school children with autism and intellectual disabilities combined; To explore the diagnostic yield of polysomnography for these individuals; To examine the feasibility and treatment effect of Applied Behavior Analysis (ABA) for insomnia, focusing on sleep maintenance difficulties, in these children. Method: Single-case experimental design with multiple baselines and with multiple participants, with a focus on feasibility. N=15 prepubertal children, aged 6-12 years, with autism and intellectual disabilities combined, and difficulties in maintaining nighttime sleep. Assessment with home polysomnography + actigraphy. Intervention with ABA, including functional analysis, measurable goals, and behavior modification based on the functional analysis. Outcome measures from actigraphy and sleep diary with multiple data points at baseline and after treatment. Feasibility is examined as adherence to assessment and treatment, as well as in a qualitative study of parental experiences.

NCT ID: NCT06375226 Recruiting - Clinical trials for Autism Spectrum Disorder

Autism and Attachment. An Explorative Study of Attachment Styles in Autistic Adults.

ASDA
Start date: March 1, 2024
Phase:
Study type: Observational

The present study examines the relationship between attachment and autism spectrum disorder (ASD) in adults.

NCT ID: NCT06373770 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Effects of Ayres Sensory Integration Therapy Versus Conservative Treatment in Autism Spectrum

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Effects of Ayres Sensory Integration Therapy Versus Conservative Treatment in Autism Spectrum

NCT ID: NCT06368687 Not yet recruiting - Clinical trials for Autism Spectrum Disorder

TRANPAS - TReating Anorexia Nervosa Plus Autism Spectrum

TRANPAS
Start date: September 1, 2024
Phase: N/A
Study type: Interventional

In a pilot study, we will validate a so-called autism care location in an inpatient ward. The care location will be adapted for patients with anorexia nervosa (AN) and concurrent autism (AN+autism). In order to investigate the effect of a tailored care location for patients with AN + autism, the evaluation will include weight development and changes in nutritional intake, eating disorder and anxiety symptoms. The overall aim is to improve treatment for this specific AN subgroup, that otherwise has a worse prognosis regarding AN recovery.

NCT ID: NCT06362733 Not yet recruiting - Clinical trials for Autism Spectrum Disorder

Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this open label trial is to examine the preliminary effectiveness of a 12-week behavioral intervention program (1 hour/week) to treat insistence on sameness (e.g., difficulty tolerating changes in routine) in youth with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of a combination of parent-training and child-focused intervention.

NCT ID: NCT06361147 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Psychoeducation of Adult Siblings of ASD People (Autism Spectrum Disorder).

Start date: March 28, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to apply a psychoeducational program in adult siblings of people with ASD as a means to provide knowledge related to the disorder and improving their quality of life. The psycho-educational program will be implemented in adult siblings of people with ASD and its effectiveness will be assessed. Participation in this program is expected to contribute in the improvement of the quality of life of the participants, their siblings with ASD and those related to them. No risk is identified.

NCT ID: NCT06359080 Completed - Clinical trials for Autism Spectrum Disorder

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)

Start date: May 8, 2022
Phase: N/A
Study type: Interventional

The hypothesis of the study is that photobiomodulation reduces symptoms of autism. Participants will be children between the ages of 2 and 7, who have been diagnosed with moderate to severe autism. Transcranial photobiomodulation will be administered to the children in the experimental condition twice a week for 10 weeks. Results will be measured through parental interviews, standardized CARS2 (Childhood Autism Rating Scales, 2nd Edition) and data collected from EEG.